From: Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms
Variable
Patient group (n = 27)
Rate (%)
X ± SE
Tumour grading
–
G1
26
96.3
G2
1
3.7
CgA (ng/ml)
215.19 ± 53.63
> 100
10
55.6 (n = 18)
< 100
8
44.4 (n = 18)
Unknown
9
Gastrin (pg/ml)
796.48 ± 99.47
27
100
0